Zeta Surgical's Mixed Reality Navigation System Receives FDA Special 510(k) Clearance for Expanded Functionality
11 Jan 2024
IND
BOSTON, Jan. 11, 2024 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, announced today that its Zeta Cranial Navigation System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded functionality through enhanced software features and compatibility with additional accessories.
The Zeta Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings. The platform received its first 510(k) clearance from the U.S. FDA in September 2023.
Dr. Roman Stolyarov, Chief Product Officer of Zeta Surgical, commented on the clearance: "This new FDA clearance enables key enhancements in usability and performance, bringing us closer to achieving our mission of dramatically reducing the barriers to surgical navigation and unlocking its benefits for a wider array of patients and procedures."
"We are thrilled to scale Zeta's deployments in the U.S., building on its early successes in clinics," said Jose Amich, Co-Founder and CEO of Zeta Surgical. "We look forward to seeing Zeta's impact on patient outcomes and in the field of neuroscience."
About Zeta Surgical
Zeta Surgical is a digital surgery company focused on improving the accuracy, safety, and accessibility of image guided procedures. Its navigation and robotics platform leverages cutting-edge computer vision and artificial intelligence to enable surgical guidance directly at the point-of-care, democratizing care by creating new possibilities in fields such as emergency care, interventional medicine, and drug delivery. Zeta Surgical was founded by Harvard graduates and faculty and is backed by leading investors. To learn more, visit: www.zetasurgical.com.
Contact:
Jose Amich
jose.amich@zetasurgical.com
SOURCE Zeta Surgical
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.